WASHINGTON — The Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to treat attention-deficit hyperactivity disorder to include warnings ...

The FDA’s new warning for stimulants used to treat ADHD cites the drugs’ high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction.

Approximately 3.5 million children in the USA, ages 3-17, take attention-deficit/hyperactivity disorder (ADHD) medications, most commonly stimulants. These include ...

Back in the 1960s, when Ritalin (methylphenidate) was first approved by the US Food and Drug Administration (FDA) for treating behavioural problems, parents and teachers alike were impressed by the ...

MONDAY, June 16, 2025 (HealthDay News) — People with ADHD might be prescribed their meds remotely without increasing their risk of addiction, a new study says. Experts have worried that prescribing ...

Please provide your email address to receive an email when new articles are posted on . Among young adults with ADHD, those taking stimulant medications had greater odds of cardiomyopathy. The ...

May 13 (UPI) --ADHD stimulant meds don't increase children's risk of psychosis, a new study says. Analyses of stimulant prescriptions among nearly 8,400 kids with attention deficit/hyperactivity ...

News Release 27-Mar-2024 ADHD stimulants may increase risk of heart damage in young adults While likelihood of cardiomyopathy grows over time, the overall risk remains low Reports and Proceedings ...

What attention-deficit hyperactivity disorder (ADHD) treatment alternatives are available for a child who has an adverse reaction to stimulants? Atomoxetine (Strattera) has been ineffective. —Janine ...

Their attraction to cannabis may be due to the effects of THC on dopamine function. Patients may use cannabis to manage their symptoms or reduce the side effects of their stimulant medications.

The combination of prescribed central nervous system stimulants, such as drugs that relieve ADHD symptoms, with prescribed opioid medications is associated with a pattern of escalating opioid intake, ...

From 2021 to 2023, stimulant marketing payments doubled and tripled for physicians and advanced practice clinicians, respectively. The increases were driven in large part by growth in marketing to ...